{"id":"NCT02487199","sponsor":"AbbVie","briefTitle":"Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease","officialTitle":"An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-II)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-09-30","primaryCompletion":"2016-12-05","completion":"2016-12-05","firstPosted":"2015-07-01","resultsPosted":"2017-12-04","lastUpdate":"2017-12-04"},"enrollment":18,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C Virus (HCV)"],"interventions":[{"type":"DRUG","name":"ombitasvir/paritaprevir/ritonavir and dasabuvir","otherNames":["Viekira Pak, paritaprevir also known as ABT-450, ombitasvir also known as ABT-267, dasabuvir also known as ABT-333"]},{"type":"DRUG","name":"ombitasvir/paritaprevir/ritonavir","otherNames":["Technivie, paritaprevir also known as ABT-450, ombitasvir also known as ABT-267"]}],"arms":[{"label":"HCV GT1a (3-DAA)","type":"EXPERIMENTAL"},{"label":"HCV GT4 (2-DAA)","type":"EXPERIMENTAL"}],"summary":"This study evaluates the efficacy and safety of ombitasvir/paritaprevir/ritonavir with or without dasabuvir in adults with hepatitis C virus (HCV) genotype 1a (GT1a) or genotype 4 (GT4) infection and with severe kidney impairment or end-stage kidney disease.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response 12 Weeks Post-treatment (SVR12)","timeFrame":"12 weeks after the last actual dose of study drug","effectByArm":[{"arm":"HCV GT1a (3-DAA)","deltaMin":100,"sd":null},{"arm":"HCV GT4 (2-DAA)","deltaMin":80,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["30291369"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":13},"commonTop":["DIARRHOEA","NAUSEA","FATIGUE","ABDOMINAL PAIN","HEADACHE"]}}